TetraGenetics is a biotech company focused on the discovery of novel therapeutics for autoimmune disease and pain. The Company is the world leader in recombinant human ion channel protein production using its proprietary TetraExpress® system. TetraGenetics uses its proteins as antigens in antibody discovery programs using a wide variety of animal systems. Its purified proteins are also used for structure determination supporting rational design of small molecule drugs.
|Employees (est.) (Oct 2019)||26||(-3%)|
TetraGenetics total Funding
TetraGenetics latest funding size
Time since last funding
|4 years ago|
|National Institute of General Medical Sciences, NXT Ventures|
When was TetraGenetics founded?
TetraGenetics was founded in 2004.
Who are TetraGenetics key executives?
TetraGenetics's key executives are R. Douglas Kahn, Theodore Clark and Paul Colussi.
How many employees does TetraGenetics have?
TetraGenetics has 26 employees.
Who are TetraGenetics competitors?
Competitors of TetraGenetics include Arrowhead Pharmaceuticals, Capstone Therapeutics and Arsanis.
Where is TetraGenetics headquarters?
TetraGenetics headquarters is located at Ithaca, NY, USA, Ithaca.
Where are TetraGenetics offices?
TetraGenetics has an office in Ithaca.
How many offices does TetraGenetics have?
TetraGenetics has 1 office.
Receive alerts for 300+ data fields across thousands of companies